Intravitreal ranibizumab for choroidal neovascularization associated with circumscribed choroidal haemangioma

Clinical and Experimental Ophthalmology

Volumn 39, Issue 9, 2011, Pages 916-918

  Querques, Giuseppe ^a   Forte, Raimondo ^a   Querques, Lea ^a   Souied, Eric H ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

AGED; B SCAN; CASE REPORT; CHOROID HEMORRHAGE; CIRCUMSCRIBED CHOROID HEMANGIOMA; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; LETTER; OPHTHALMOSCOPY; RETINA MACULA CYSTOID EDEMA; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROID NEOPLASMS; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEMANGIOMA; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 82955213012     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02580.x     Document Type: Letter

References (5)

1. Shields CL, Honavar SG, Shields JA, Cater J, Demirci H. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 2001; 108: 2237-48.
2. Ruby AJ, Jampol LM, Goldberg MF, Schroeder R, Anderson-Nelson S. Choroidal novascularization associated with choroidal hemangiomas. Arch Ophthalmol 1992; 110: 658-61.
3. Tuncer S, Demirci H, Shields CL, Shields JA. Polypoidal choroidal vasculopathy following photodynamic therapy for choroidal hemangioma. Eur J Ophthalmol 2009; 19: 159-62.
4. Leys AM, Silva R, Inhoffen W, Tatar O. Neovascular growth following photodynamic therapy for choroidal hemangioma and neovascular regression after intravitreous injection of triamcinolone. Retina 2006; 26: 693-7.
5. Sadda SR, Stoller G, Boyer DS, Blodi BA, Shapiro H, Ianchulev T. Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor study. Retina 2010; 30: 1390-9.